Automation, robots and software can probably dispense drugs faster and more accurately, Michael Rea, PharmD, founder of medication therapy management firm Rx Savings, told Drug Topics.
“Dispensing is dying,” Becky Winslow, PharmD, senior pharmacogenomics specialist at Admera Health in Plainfield, N.J., told Drug Topics. “I was a pharmacy manager for Walmart 21 years ago and started plotting my way out within two years. I could see the business model just wasn’t sustainable.”
In the next 10 years, the pharmacy industry will likely transform from dispensing a product to providing personalized treatment focused on improving clinical outcomes, the pharmacy leaders predicted.
If pharmacists were able to be more involved with patients, that could have a significant impact on lowering their total cost of care, Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives for the National Community Pharmacists Association, told Drug Topics.
Patients are likely to be motivated to use pharmacies that prove they can improve patient outcomes, the pharmacists said.
Read the full article here.
More articles on pharmacy:
CVS, Walgreens plan to test for COVID-19 in parking lots
6 things to know about the leading drug being tested to treat COVID-19
USP panel sends revised compounding standards back for expert review
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.